

Author: Czarnecki Andrzej
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.31, Iss.1, 2008-01, pp. : 1-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Care for the elderly: how can it be improved?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 260, 2000-01 ,pp. :


Statins: can CRP levels determine coronary risk?
Inpharma, Vol. 1, Iss. 1295, 2001-01 ,pp. :






Communication of Medical Product Risk: How Effective is Effective Enough?
By Goldman S.A.
Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. :